Thalidomide, the notorious drug which caused horrendous birth defects in the 1950s and 1960s, is close to making a comeback as an anticancer drug. Drug firm Celgene of Warren, New Jersey, has applied to European drug authorities for permission to sell thalidomide to treat multiple myeloma, a fatal cancer of the bone marrow. In clinical trials the drug performed well against the disease. It will take Europe seven months or more to reach a verdict on the drug, which will not be prescribed to pregnant women or those considering having children.
To continue reading, today with our introductory offers
Advertisement
More from New Å®ÉúСÊÓƵ
Explore the latest news, articles and features
Humans
Mystery of the ancient giant stone jars of Laos may have been solved
News
Mind
Floatation tanks deployed to combat PTSD after devastating wildfires
News
Mind
What is love? Even a meeting on the subject can't find the answer
News
Mind
How I used psychology to come back from the worst year of my life
Features
Popular articles
Trending New Å®ÉúСÊÓƵ articles
1
The ‘doomsday’ glacier’s giant ice shelf is about to break away
2
How I used psychology to come back from the worst year of my life
3
PCOS has been officially renamed PMOS, and it’s a momentous move
4
The 3 things you need to know about protein, according to an expert
5
Cleaning up air pollution could weaken vital AMOC ocean current
6
Why autism pioneer Uta Frith wants to dismantle the spectrum
7
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
8
Where did the laws of physics come from? I think I've found the answer
9
Melting of Greenland ice sheet could release methane 'fire ice'
10
A new tectonic plate boundary could be forming in southern Africa